Newsletter #4 - Nov 2021, Preparing for next year...
Preparing for next year...We continue to make good progress with the clinical activities for CT001, and 2022 will be a very interesting year for the company. We have started the work on our US development strategy and with the first US patent we are off to a really good start. We have also started interacting with US companies and authorities, more to come in 2022. We continue to strengthen the team, and with Benedikte Bandak as Head of Clinical Development and Operations we are now ready for executing on the late-stage development phase - see medwatch-link